New Zealand markets closed

MiNK Therapeutics, Inc. (INKT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9600-0.0300 (-3.03%)
At close: 04:00PM EDT
0.9502 -0.01 (-1.02%)
After hours: 06:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
13,846
15,490
23,115
13,966
9,509
-
Selling general and administrative
7,051
7,431
7,834
4,640
1,288
-
Total operating expenses
20,897
22,921
30,949
28,359
10,797
-
Operating income or loss
-20,897
-22,921
-30,949
-28,359
-10,797
-
Interest expense
-
-
-
2,432
2,441
1,561
Total other income/expenses net
-
-0.01
2,705
577.435
-3,001
-
Income before tax
-20,585
-22,458
-27,991
-30,213
-16,239
-
Income from continuing operations
-20,585
-22,458
-27,991
-30,213
-16,239
-
Net income
-20,585
-22,458
-27,991
-30,213
-16,239
-
Net income available to common shareholders
-20,585
-22,458
-27,991
-30,213
-16,239
-
Basic EPS
-0.73
-
-0.83
-1.16
-0.57
-0.93
Diluted EPS
-0.73
-
-0.83
-1.16
-0.57
-0.93
Basic average shares
34,172
-
33,673
26,025
28,395
25,549
Diluted average shares
34,172
-
33,673
26,025
28,395
25,549